Reducing CVD Risk In The Metabolic Syndrome And Type 2 Diabetes: Novel Approaches To Studies Of Lipoprotein Metabolism
Funder
National Health and Medical Research Council
Funding Amount
$548,669.00
Summary
The incidence of obesity and diabetes is increasing in Australia. With these two conditions comes an increase in cardiovascular disease risk. Elevated blood lipids are an important component of this increased. Weight loss and cholesterol lowering drugs are first line therapies for obesity and diabetes, respectively. Niacin is effective at lowering lipids and raising HDL cholesterol, but the mechanisms responsible for these changes have not been determined.